In response to the COVID-19 situation, OCLI is following enhanced safety protocols consistent with guidelines put forth by the CDC and the World Health Organization (WHO) to protect our patients and colleagues. Click here to learn about how we are keeping you safe.

FDA Approves Aspheric AcrySof IQ toric IOL

March 12, 2009

Alcon Labs has recently announced that the U.S. Food and Drug Administration has approved Alcon’s Aspheric AcrySof IQ Toric IOL for use in cataract surgery patients with astigmatism. The new AcrySof Toric Lens has an enhanced Aspheric Optic for improved image quality, increased contrast sensitivity and quality distance vision without spectacle correction.

The first AcrySof® Toric Lens was introduced in 2005 and quickly became the leading toric lens in the market, due to its predictable power outcomes and excellent rotational stability. These benefits are largely realized due to the strengths of the AcrySof® IOL material and proprietary single-piece design.

I have gotten superb results in implanting this lens in my cataract patients with astigmatism. These patients are able to attain incredible distance vision without the need for glasses or contacts! I expect this new modification to further improve my patients ability to see clearly, especially in low contrast situations such as night driving.

Back to our blog

Services offered at OCLI

Our world-class team of professionals at OCLI can help you with the latest treatment options for you.

Request an appointment

* required